Total Utang marang Modal Biodesix Corp (BDSX)

Biodesix - logo grafis emiten BDSX

Biodesix, Inc. (BDSX) brings together leading data scientists and biologists driven by the creation of innovative early tumor detection systems. However, the slow integration of tests into insurance plans and marketing expenses create a risk of prolonged deficits in profitability. The historical price action of the total debt-to-equity ratio on GURU.Markets is 7.44, while the business relies on the US domestic market, remaining sensitive to component supply chain disruptions.

biodesix.com (BDSX): Rasio Utang marang Ekuitas saka 04.07.2022 nganti 30.10.2026

Rincian metrik lan analitis perusahaan Biodesix Corporation (BDSX)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Biodesix|BDSX - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Biodesix|BDSX - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham Biodesix|BDSX - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku biodesix.com|BDSX - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Biodesix, Inc.|BDSX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Biodesix, Inc.|BDSX - Kewajiban utang agregat|Utang marang nilai buku Biodesix|BDSX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Biodesix|Likuiditas cepet biodesix.com
- data bathi resik lan rasio valuasi:
BDSX - Bathi perusahaan
Pambiji fundamental perusahaan:Biodesix
Produk dadi Biodesix, Inc.

The development of Biodesix, Inc. (BDSX) depends critically on the success of R&D projects amid limited commercial revenue, making capital control a priority. By analyzing the current total debt-to-equity ratio, an investor can see the proportion of borrowed funds to equity, allowing for an assessment of leverage risk and business resilience in an environment of high cash burn.

Analisis pesaing Biodesix, Inc.

CAI (Caris Life Sciences) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Guardant Health Inc (GH)|Total Utang marang Modal VCYT|Total Utang marang Modal Celcuity Therapeutics (CELC)|Utang marang Ekuitas GRAIL, Inc. GRAL|MYGN: Rasio Utang marang Ekuitas|Castle Biosciences, Inc. - Total Utang marang Modal|Burning Rock Biotech Limited (BNR) - Rasio Total Utang marang Ekuitas|VNRX: Total Utang marang Modal|Utang marang Modal Precipio Inc (PRPO)|Utang marang Ekuitas Check-Cap Ltd|MYNZ: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas OCX (OncoCyte)